iifl-logo

DSP Healthcare Fund Direct G

DSP Healthcare Fund Direct G

Fund Name

DSP Mutual Fund

Scheme Name

DSP Healthcare Fund Direct G

AMC

DSP Mutual Fund

Type

:  Open

Category

Equity - Pharma

Launch Date

12-Nov-2018

Fund Manager

Chirag Dagli

Net Assets (Rs. cr)

3142.36

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

DSP Healthcare Fund Direct G - Nav Details

Nav Date

:  10-Jun-2026

NAV [Rs.]

:  46.286

Buy/Resale Price [Rs.]

0

Sell/Repurchase Price [Rs.]

0

Entry Load %

Nil

Exit Load %

1.00% - If redeemed/switched out within 12 months from the date of allotment. Nil - If redeemed/switched out after 12 months from the date of allotment.

DSP Healthcare Fund Direct G- NAV Chart

DSP Healthcare Fund Direct G- Performance(%)

Returns above 1 yr. are annualized

1W
1M
3M
6M
1Y
3Y
5Y
Since INC
Scheme Returns
2.82
4.24
12.68
6.74
10.03
24.11
15.98
22.65
Category Avg
-1.48
3.96
6.4
5.15
10
23.45
13.95
14.83
Category Best
-0.02
6.29
10.67
11.79
20.13
27.28
16.38
29.32
Category Worst
-2.63
-0.92
-0.53
-2.66
1.77
19.09
10.35
-1.67

DSP Healthcare Fund Direct G- Latest Dividends

No Records Found

DSP Healthcare Fund Direct G- Investment Details

Min. Investment(Rs.)

100

Increm.Investment(Rs.)

100

In & Out

In

InName Of The CompanyNo Of Shares
--

Out

InName Of The CompanyNo Of Shares
Medplus Health1,92,078
Corona Remedies27,314

Fund Holdings

Asset Type
Instrument Name
Industry
Net Assets(%)
No of Shares
Mkt Value(Cr.)
Equity & Equity related Investments
EquitySun Pharma.Inds.Pharmaceuticals & Biotechnology8.351535592276.28
EquityIpca Labs.Pharmaceuticals & Biotechnology7.811696381258.59
EquityCiplaPharmaceuticals & Biotechnology7.681813462254.06
Foreign EquityIllumina IncHealthcare Services7.53160400249.32
EquitySai LifePharmaceuticals & Biotechnology6.861957356227.05
Foreign EquityGlobus Medical IncHealthcare Equipment & Supplies6.34268800209.93
EquityGland PharmaPharmaceuticals & Biotechnology6.26920673207.15
EquityApollo HospitalsHealthcare Services4.81194767159.25
EquityCohance LifePharmaceuticals & Biotechnology4.153179881137.21
EquityLaurus LabsPharmaceuticals & Biotechnology3.76914169124.50
EquityVijaya Diagnost.Healthcare Services3.70935530122.41
EquityAlembic PharmaPharmaceuticals & Biotechnology3.211442516106.18
EquityP & G Health LtdPharmaceuticals & Biotechnology2.9215928896.46
EquityPfizerPharmaceuticals & Biotechnology2.7920064492.26
EquityKovai MedicalHealthcare Services2.6816515688.53
Foreign EquityIntuitive Surgical IncHealthcare Equipment & Supplies2.301876876.01
EquityIndoco RemediesPharmaceuticals & Biotechnology2.06324568268.04
EquityConcord BiotechPharmaceuticals & Biotechnology1.5849668852.21
EquityEmcure PharmaPharmaceuticals & Biotechnology1.5129389249.84
EquityICICI LombardInsurance1.3124141343.26
EquityNephrocare HealtHealthcare Services1.1563498338.01
EquityAarti DrugsPharmaceuticals & Biotechnology0.9885215532.41
EquityUnichem Labs.Pharmaceuticals & Biotechnology0.9085511129.87
Foreign EquityAbbott LaboratoriesPharmaceuticals & Biotechnology0.783160025.80
EquityAlkem LabPharmaceuticals & Biotechnology0.623733420.52
EquityJupiter Life LinHealthcare Services0.389411712.49
EquityLaxmi DentalHealthcare Equipment & Supplies0.202804016.52
Foreign EquityGrail IncHealthcare Services0.1887335.97

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

MY WEALTH AT RETIREMENT

Calculate the worth of your wealth at retirement

Key information

Fund House:
DSP Mutual Fund
Incorporation Date:
13-May-1996
Total Assets Managed (Cr.):
2,28,622.33
Trustee/s:
Mr.T.S. Krishna Murthy, DSP Trustee Private Limit, Shitin D. Desai, S.S.N. Moorthy, Mrs. Pravin tripathi, Ms. Dharmishta Rawal
Chairman:
NA
CEO / MD:
Mr. Kalpen Parekh
CIO:
NA
President:
NA
Director/s:
Uday Khanna, Mr.Hemendra M. Kothari, Mr. S.S. Mundra, Ms. Aditi Kothari Desai, Mr.Dhananjay Mungale, Mr. S. Ramadorai
Compliance Officer/s:
Pritesh Majmudar
Investor Service Officer/s:
NA
Fund Manager/s:
Chirag Dagli
Auditors:
S.R. BATLIBOI &Co.LLP, M/s.Walker Chandiok & Co.

OTHER INFORMATION

Registered Office:
The Ruby, 25th Floor, 29, Senapati Bapat Marg, Dadar (West), Mumbai - 400028.
Contact Nos:
022-66578000
Fax:
022-66578181
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.